Pricing Log in Create free account
Friday 6 November 2026 Export ILMN’s income statement to Excel — free account

Illumina, Inc.

ILMN Healthcare Diagnostics & Research

Illumina, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $4.3 billion, down 0.66% from fiscal 2024.

Revenue
+4.15%
EPS
+49.0%
Free cash flow
+49.8%
Total debt
+80.0%

Quarter to September 2026, against a year earlier

209.82 16.72 −7.38%
Market cap
$31.5B
P/E
35.6×
Fwd P/E
46.4×
Dividend yield
—
F-score
8/9
Altman Z
4.39
Beneish M
−2.51
Dividend safety
n/a
Overview Business Profile Earnings & Analysis
Financials
Income Statement Balance Sheet Cash Flow Metrics & Ratios
Segments Valuation Filings

Illumina, Inc. (ILMN) EV/Sales

Alert me on EV/Sales

As of 5 November 2026, Illumina, Inc. (ILMN) trades at a EV/Sales of 7.2×. Over the past ten years it has ranged from 2.7× (April 2025) to 21.8× (February 2021); the current reading is higher than 33% of that period. That is above the Diagnostics & Research industry median of 5.2× and above the Healthcare sector median of 3.5×.

EV/Sales, daily

Embed this chart

Annual newest first

Period EV/Sales Change
FY2025 4.8× (5.42%)
FY2024 5.0× 1.79%
FY2023 4.9× (26.65%)
FY2022 6.7× (46.35%)
FY2021 12.6× (20.37%)
FY2020 15.8× 22.47%
FY2019 12.9× 2.81%
FY2018 12.5× 10.69%
FY2017 11.3× 47.37%
FY2016 7.7× (36.30%)

Quarterly newest first

Period EV/Sales Change
Sep 2026 9.3× 52.94%
Jun 2026 6.1× 35.92%
Mar 2026 4.5× (5.89%)
Dec 2025 4.8× 38.54%
43 more quarters

Against its own ten years

Low 2.7× High 21.8×
Ten-year median 10.2×
Current reading's percentile 36

EV/Sales against peers

Company EV/Sales
LH Labcorp Holdings Inc. compare 2.4×
DGX Quest Diagnostics Incorporated compare 2.8×
IQV IQVIA Holdings Inc. compare 3.3×
A Agilent Technologies, Inc. compare 6.8×
ILMN Illumina, Inc. 7.2×
MTD Mettler-Toledo International, Inc. compare 8.7×
WAT Waters Corporation compare 8.7×
IDXX IDEXX Laboratories, Inc. compare 11.3×
GH Guardant Health, Inc. compare 16.6×
Diagnostics & Research industry median 5.2×
Healthcare sector median 3.5×
Market median 2.1×

What EV/Sales is

EV/Sales tells an investor how the value of a whole company, counting its debt and cash, compares with the sales it brings in.

((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ Revenue (TTM)

The full definition of EV/Sales →

More on ILMN